Form 8-K - Current report:
SEC Accession No. 0001104659-24-132921
Filing Date
2024-12-31
Accepted
2024-12-31 17:17:30
Documents
15
Period of Report
2024-12-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2432245d1_8k.htm   iXBRL 8-K 37998
2 EXHIBIT 99.1 tm2432245d1_ex99-1.htm EX-99.1 115953
  Complete submission text file 0001104659-24-132921.txt   415066

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tdacu-20241224.xsd EX-101.SCH 4374
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tdacu-20241224_def.xml EX-101.DEF 27842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tdacu-20241224_lab.xml EX-101.LAB 38247
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tdacu-20241224_pre.xml EX-101.PRE 26462
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2432245d1_8k_htm.xml XML 7703
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42451 | Film No.: 241593768
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)